Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2.
O'Reilly
Fiona
F
Dermatology Branch, National Cancer Institute, Bethesda, MD 20892-1908, USA.
Feldman
Elizabeth
E
Yang
James
J
Hwu
Patrick
P
Turner
Maria L
ML
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D012867:Skin / Q000473:pathology
D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins